How many stocks are there of MDxHealth?
The current number of stocks of MDxHealth is 15.87 M undefined.
MDxHealth Stocks 2024
MDxHealth Stocks
15.87 M
Ticker
MDXH.BR
ISIN
BE0003844611
WKN
A0J3N3
In 2024, MDxHealth had 15.87 M outstanding stocks, a 0% change from the 15.87 M stocks in the previous year.
The MDxHealth Stocks history
| YEAR | NUMBER OF STOCKS (undefined USD) |
|---|---|
| 2027e | 15.87 |
| 2026e | 15.87 |
| 2025e | 15.87 |
| 2024e | 15.87 |
| 2023e | 15.87 |
| 2022 | 15.87 |
| 2021 | 12.19 |
| 2020 | 8.32 |
| 2019 | 6.26 |
| 2018 | 5.76 |
| 2017 | 4.99 |
| 2016 | 4.61 |
| 2015 | 4.13 |
| 2014 | 3.48 |
| 2013 | 3 |
| 2012 | 2.21 |
| 2011 | 1.72 |
| 2010 | 1.32 |
| 2009 | 1.32 |
| 2008 | 1.18 |
| 2007 | 1.08 |
| 2006 | 1.05 |
| 2005 | 1 |
| 2004 | 1 |
| 2003 | 1 |
MDxHealth shares outstanding BE0003844611 · A0J3N3
The number of shares was MDxHealth in 2023 — This indicates how many shares 15.87 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
3 years
5 years
10 years
25 Years
Max
Number of stocks
Details
Revenue, EBIT and Earnings per share
ⓘRevenue Per Share
Revenue per share represents the total revenue MDxHealth earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.
EBIT Per Share
EBIT per share indicates MDxHealth's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.
Income Per Share
Income per share, or earnings per share (EPS), reveals the portion of MDxHealth’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.
Expected Values
Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating MDxHealth's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.
| Number of stocks | |
|---|---|
| 2003 | 1 M Aktien |
| 2004 | 1 M Aktien |
| 2005 | 1 M Aktien |
| 2006 | 1.05 M Aktien |
| 2007 | 1.08 M Aktien |
| 2008 | 1.18 M Aktien |
| 2009 | 1.32 M Aktien |
| 2010 | 1.32 M Aktien |
| 2011 | 1.72 M Aktien |
| 2012 | 2.21 M Aktien |
| 2013 | 3 M Aktien |
| 2014 | 3.48 M Aktien |
| 2015 | 4.13 M Aktien |
| 2016 | 4.61 M Aktien |
| 2017 | 4.99 M Aktien |
| 2018 | 5.76 M Aktien |
| 2019 | 6.26 M Aktien |
| 2020 | 8.32 M Aktien |
| 2021 | 12.19 M Aktien |
| 2022 | 15.87 M Aktien |
| 2023e | 15.87 M Aktien |
| 2024e | 15.87 M Aktien |
| 2025e | 15.87 M Aktien |
| 2026e | 15.87 M Aktien |
| 2027e | 15.87 M Aktien |
MDxHealth Aktienanalyse
What does MDxHealth do?
MDxHealth SA was founded in 2003 and is a publicly traded company based in Belgium, specializing in the development and marketing of molecular diagnostic tests for cancer diagnosis. The company focuses on developing tests for the diagnosis of prostate, bladder, and kidney cancer, as well as tests for monitoring the progression of these cancer types. The business model of MDxHealth is to develop state-of-the-art molecular diagnostics for cancer medicine and make them accessible to medical professionals and pathologists. The company has a strong presence in the US and Europe, and works closely with leading cancer centers and clinics to promote the use of the tests and improve their effectiveness. MDxHealth also provides support to its customers in interpreting test results and choosing the best treatment options for patients. The company has different divisions tailored to the specific needs of patients, doctors, and pathologists. The main divisions are the oncology division and the urology division. In the oncology division, MDxHealth offers various tests for prostate cancer, including the Prognostic Oncotype DX Test used for predicting the progression of prostate cancer. The urology division of MDxHealth focuses on developing tests for bladder cancer and kidney cancer. The key tests in this division include the ConfirmMDx Test used for diagnosing bladder cancer, and the SelectMDx Test used for diagnosing aggressive prostate cancer. MDxHealth also has a significant presence in genomics and personalized medicine. The company partners with the University of Miami Miller School of Medicine to research and improve the application of genetic tests in cancer diagnosis and treatment. MDxHealth also collaborates closely with other leading research institutions and cancer centers to drive innovation in molecular diagnostics. Overall, MDxHealth offers a wide range of molecular diagnostic tests for cancer diagnosis and monitoring. The company has a strong presence in the US and Europe, and works closely with leading cancer centers and clinics to promote the use of the tests and improve their effectiveness. MDxHealth is a key player in the field of molecular diagnostics and has the potential to improve the lives of cancer patients worldwide. MDxHealth ist eines der beliebtesten Unternehmen auf Eulerpool.com.Stocks Details
Evaluating MDxHealth's Shares Outstanding
MDxHealth's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.
Year-to-Year Comparison
Tracking the changes in MDxHealth’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.
Impact on Investments
For investors, understanding MDxHealth’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.
Interpreting Changes in Shares Outstanding
Variances in MDxHealth’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.
Frequently Asked Questions about MDxHealth stock
What does Number of Shares / OutstandingShares mean?
The outstanding shares (or issued shares) of MDxHealth are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.
How has the number of shares of MDxHealth evolved in recent years?
The number of shares of MDxHealth has increased by 0% gestiegen compared to last year.
What does the number of shares mean for investors?
The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.
Why does the number of stocks fluctuate?
There are various factors that can lead to a change. MDxHealth as a company can issue new shares, carry out stock splits or reverse splits.
Does the number of shares have an impact on the performance of MDxHealth?
There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).
How much dividend does MDxHealth pay?
Over the past 12 months, MDxHealth paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, MDxHealth is expected to pay a dividend of 0 USD.
What is the dividend yield of MDxHealth?
The current dividend yield of MDxHealth is .
When does MDxHealth pay dividends?
MDxHealth pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of MDxHealth?
MDxHealth paid dividends every year for the past 0 years.
What is the dividend of MDxHealth?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is MDxHealth located?
MDxHealth is assigned to the 'Health' sector.
Wann musste ich die Aktien von MDxHealth kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of MDxHealth from 7/29/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 7/29/2024.
When did MDxHealth pay the last dividend?
The last dividend was paid out on 7/29/2024.
What was the dividend of MDxHealth in the year 2023?
In the year 2023, MDxHealth distributed 0 USD as dividends.
In which currency does MDxHealth pay out the dividend?
The dividends of MDxHealth are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von MDxHealth
Our stock analysis for MDxHealth Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of MDxHealth Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
